Development of a Novel Cofilin Inhibitor for the Treatment of Hemorrhagic Brain Injury

Development of a Novel Cofilin Inhibitor for the Treatment of Hemorrhagic Brain Injury

Bibliographic Details
Main Author: Alaqel, Saleh I.
Language:English
Published: University of Toledo / OhioLINK 2019
Subjects:
Medicine
Neurology
Neurobiology
Pharmacy Sciences
Online Access:http://rave.ohiolink.edu/etdc/view?acc_num=toledo1571073888078636
id ndltd-OhioLink-oai-etd.ohiolink.edu-toledo1571073888078636
record_format oai_dc
spelling ndltd-OhioLink-oai-etd.ohiolink.edu-toledo15710738880786362021-08-03T07:13:05Z Development of a Novel Cofilin Inhibitor for the Treatment of Hemorrhagic Brain Injury Alaqel, Saleh I. Medicine Neurology Neurobiology Pharmacy Sciences Intracerebral hemorrhage (ICH) is a devastating form of stroke with high mortality. Traditional treatments for ICH are primarily supportive, including blood pressure control, hemostasis, and rehabilitation. To date, no medical or surgical intervention has been proven successful. Most of the pharmacological therapies have failed to pro- vide favorable outcomes or reduce the mortality due to the complexity of the cellular mechanisms and diversity of signaling cascades involved after ICH. The multifacto- rial secondary injury induced by ICH requires a new therapeutic strategy targeting multiple pathways to lessen the impact of brain injury and improve patient survival. Our previous studies have proposed cofilin as a potential therapeutic drug target for ICH. After obtaining convincing results on the role of cofilin in brain pathol- ogy, we embarked on designing and synthesizing a first-in-class small molecule in- hibitor of cofilin, SZ-3 to effectively target multiple pathways to prevent neurological damage and decrease secondary complications after ICH. The potential binding and inhibiting activity of SZ-3 was tested on isolated actin by measuring the F-actin length subjected to cofilin. SZ-3 was able to decrease cofilin severing activity, which also suggested a reasonable affinity of the compound. SZ-3 treatment was found to attenuate microglial activation, suppress migration, and proliferation. Human mi- croglial cultures subjected to thrombin, as an experimental model for hemorrhagic stroke, treated with SZ-3 3h later showed a significant decrease in nitric oxide (NO), and tumor necrosis factor (TNF-α) production after LPS stimulation. Besides, the compound significantly increased phosphocofilin and decreased protein expression of protease-activated receptor-1 (PAR1) in thrombin-activated microglia. Furthermore, the compound showed a significant increase in cell viability, induced neuroprotection by significantly decreasing nuclear factor-kappa B (NF-kB), caspase-3, and high- temperature requirement (HtrA2) following ICH. Finally, SZ-3 showed promising neurobehavioral outcome in an in vivo model of ICH, which supports the future ex- tensive in vivo studies as a new lead compound for the treatment of hemorrhagic and ischemic strokes. 2019 English text University of Toledo / OhioLINK http://rave.ohiolink.edu/etdc/view?acc_num=toledo1571073888078636 http://rave.ohiolink.edu/etdc/view?acc_num=toledo1571073888078636 unrestricted This thesis or dissertation is protected by copyright: all rights reserved. It may not be copied or redistributed beyond the terms of applicable copyright laws.
collection NDLTD
language English
sources NDLTD
topic Medicine
Neurology
Neurobiology
Pharmacy Sciences
spellingShingle Medicine
Neurology
Neurobiology
Pharmacy Sciences
Alaqel, Saleh I.
Development of a Novel Cofilin Inhibitor for the Treatment of Hemorrhagic Brain Injury
author Alaqel, Saleh I.
author_facet Alaqel, Saleh I.
author_sort Alaqel, Saleh I.
title Development of a Novel Cofilin Inhibitor for the Treatment of Hemorrhagic Brain Injury
title_short Development of a Novel Cofilin Inhibitor for the Treatment of Hemorrhagic Brain Injury
title_full Development of a Novel Cofilin Inhibitor for the Treatment of Hemorrhagic Brain Injury
title_fullStr Development of a Novel Cofilin Inhibitor for the Treatment of Hemorrhagic Brain Injury
title_full_unstemmed Development of a Novel Cofilin Inhibitor for the Treatment of Hemorrhagic Brain Injury
title_sort development of a novel cofilin inhibitor for the treatment of hemorrhagic brain injury
publisher University of Toledo / OhioLINK
publishDate 2019
url http://rave.ohiolink.edu/etdc/view?acc_num=toledo1571073888078636
work_keys_str_mv AT alaqelsalehi developmentofanovelcofilininhibitorforthetreatmentofhemorrhagicbraininjury
_version_ 1719456752130326528

Similar Items